Curiosity: Running BE studies with more than 2 arms [Design Issues]

posted by jag009  – NJ, 2012-06-11 17:01 (4758 d 17:36 ago) – Posting: # 8683
Views: 11,195

Hi everyone,

I have a question. If there is a FDA a draft BE guidance for a product specifing the type of 2 way crossover studies that need to be conducted:
  1. 2-way crossover (Test vs Reference) fasting
  2. 2-way crossover (Test vs Reference) fed
What if we end up running a 4-way crossover involving 3 test formulations vs 1 Reference for each study? Everything will be the same except for 2 extra arms. The reason we are doing this is because we want to bypass the pilot study.

Would that be doable? The only issue I can see (beside the cost) is the ethical issue because we will (obviously) draw more blood samples per subject, and may have a larger sample size due to potential dropouts since the length of the study is doubled.

I believe FDA allows the use of an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations.

Do you think the agency will have an issue with the approach?

Thanks

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
45 visitors (0 registered, 45 guests [including 9 identified bots]).
Forum time: 10:38 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5